交易 RAPT Therapeutics, Inc. - RAPT CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.07 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
RAPT Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 7.90 | -0.05 | -0.63% | 7.95 | 8.04 | 7.82 |
Apr 17, 2024 | 7.98 | -0.14 | -1.72% | 8.12 | 8.25 | 7.91 |
Apr 16, 2024 | 8.08 | -0.28 | -3.35% | 8.36 | 8.48 | 8.03 |
Apr 15, 2024 | 8.51 | -0.54 | -5.97% | 9.05 | 9.10 | 8.40 |
Apr 12, 2024 | 9.18 | -0.05 | -0.54% | 9.23 | 9.26 | 8.96 |
Apr 11, 2024 | 9.34 | 0.37 | 4.12% | 8.97 | 9.60 | 8.88 |
Apr 10, 2024 | 8.98 | 0.65 | 7.80% | 8.33 | 8.98 | 8.03 |
Apr 9, 2024 | 8.42 | 0.28 | 3.44% | 8.14 | 8.55 | 8.14 |
Apr 8, 2024 | 8.28 | 0.45 | 5.75% | 7.83 | 8.32 | 7.77 |
Apr 5, 2024 | 7.88 | -0.08 | -1.01% | 7.96 | 8.19 | 7.79 |
Apr 4, 2024 | 7.98 | -0.36 | -4.32% | 8.34 | 8.61 | 7.96 |
Apr 3, 2024 | 8.34 | 0.23 | 2.84% | 8.11 | 8.34 | 8.09 |
Apr 2, 2024 | 8.19 | -0.09 | -1.09% | 8.28 | 8.33 | 8.08 |
Apr 1, 2024 | 8.41 | -0.39 | -4.43% | 8.80 | 8.84 | 8.38 |
Mar 28, 2024 | 8.93 | 0.13 | 1.48% | 8.80 | 8.96 | 8.65 |
Mar 27, 2024 | 8.88 | 0.50 | 5.97% | 8.38 | 8.97 | 8.32 |
Mar 26, 2024 | 8.37 | 0.19 | 2.32% | 8.18 | 8.49 | 8.18 |
Mar 25, 2024 | 8.24 | -0.07 | -0.84% | 8.31 | 8.52 | 8.18 |
Mar 22, 2024 | 8.32 | -0.06 | -0.72% | 8.38 | 8.53 | 8.23 |
Mar 21, 2024 | 8.48 | -0.20 | -2.30% | 8.68 | 9.04 | 8.46 |
RAPT Therapeutics, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 9, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Rapt Therapeutics Inc Earnings Release Q1 2024 Rapt Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Wednesday, May 22, 2024 | ||
時間 (UTC) 17:00 | 國家 US
| 事件 RAPT Therapeutics Inc Annual Shareholders Meeting RAPT Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, May 23, 2024 | ||
時間 (UTC) 17:00 | 國家 US
| 事件 Rapt Therapeutics Inc Annual Shareholders Meeting Rapt Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Friday, August 9, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 Rapt Therapeutics Inc Earnings Release Q2 2024 Rapt Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 1.527 | 3.813 | 5.042 | 0 | 0 |
總營業費用 | 87.322 | 73.022 | 58.256 | 43.629 | 36.947 |
銷售/一般/行政費用,總計 | 20.24 | 16.037 | 12.771 | 8.719 | 5.18 |
研究與開發 | 67.082 | 56.985 | 45.485 | 34.91 | 31.767 |
營業收入 | -85.795 | -69.209 | -53.214 | -43.629 | -36.947 |
其他,淨值 | 1.957 | 0.005 | 1.312 | 1.292 | 0.8 |
稅前淨收入 | -83.838 | -69.204 | -51.902 | -42.337 | -36.147 |
稅後淨收入 | -83.838 | -69.204 | -52.892 | -42.997 | -36.147 |
未計算非常項目前的淨收益 | -83.838 | -69.204 | -52.892 | -42.997 | -36.147 |
非常規項目總計 | |||||
淨收入 | -83.838 | -69.204 | -52.892 | -42.997 | -36.147 |
普通股股東可獲收益 (不含非經常性項目) | -83.838 | -69.204 | -52.892 | -42.997 | -36.147 |
普通股股東可獲收益 (含非經常性項目) | -83.838 | -69.204 | -52.892 | -42.997 | -36.147 |
攤薄淨收入 | -83.838 | -69.204 | -52.892 | -42.997 | -36.147 |
攤薄後加權平均股 | 32.5404 | 27.3903 | 24.1343 | 22.7504 | 22.7504 |
扣除特別項目的每股攤薄盈利 | -2.57643 | -2.52659 | -2.19157 | -1.88995 | -1.58885 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -2.57643 | -2.52659 | -2.19157 | -1.88995 | -1.58885 |
收入 | 1.527 | 3.813 | 5.042 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0.886 |
收入 | 0 | 0 | 0 | 0 | 0.886 |
總營業費用 | 28.364 | 31.562 | 24.431 | 21.678 | 19.795 |
銷售/一般/行政費用,總計 | 6.722 | 5.988 | 4.977 | 5.079 | 5.436 |
研究與開發 | 21.642 | 25.574 | 19.454 | 16.599 | 14.359 |
營業收入 | -28.364 | -31.562 | -24.431 | -21.678 | -18.909 |
其他,淨值 | 3.084 | 2.291 | 1.48 | 0.443 | -0.275 |
稅前淨收入 | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 |
稅後淨收入 | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 |
未計算非常項目前的淨收益 | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 |
淨收入 | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 |
普通股股東可獲收益 (不含非經常性項目) | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 |
普通股股東可獲收益 (含非經常性項目) | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 |
攤薄淨收入 | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 |
攤薄後加權平均股 | 38.3287 | 38.2805 | 35.7158 | 33.6843 | 31.1403 |
扣除特別項目的每股攤薄盈利 | -0.65956 | -0.76464 | -0.6426 | -0.63041 | -0.61605 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.65956 | -0.76464 | -0.6426 | -0.63041 | -0.61605 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 252.694 | 192.973 | 115.598 | 80.506 | 65.062 |
現金和短期投資 | 249.068 | 189.654 | 111.51 | 77.383 | 63.798 |
現金等價物 | 38.946 | 24.027 | 24.918 | 77.383 | 63.798 |
預付的費用 | 3.626 | 3.319 | 4.088 | 3.123 | 1.264 |
總資産 | 266.209 | 198.636 | 118.969 | 84.602 | 69.61 |
物業/廠房/設備,總計 - 淨額 | 9.479 | 2.741 | 2.982 | 3.707 | 4.159 |
物業/廠房/設備,總計 - 總額 | 17.728 | 10.425 | 10.064 | 9.766 | 9.128 |
累計折舊,總計 | -8.249 | -7.684 | -7.082 | -6.059 | -4.969 |
其他長期資産,總計 | 4.036 | 2.922 | 0.389 | 0.389 | 0.389 |
流動負債總額 | 14.224 | 9.595 | 11.742 | 9.256 | 4.643 |
應付賬款 | 3.365 | 1.999 | 2.383 | 1.143 | 1.771 |
預提費用 | 10.827 | 6.326 | 4.935 | 3.642 | 2.488 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.032 | 1.27 | 4.424 | 4.471 | 0.384 |
負債總額 | 21.043 | 12.256 | 14.79 | 11.481 | 5.612 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 6.819 | 2.661 | 3.048 | 2.225 | 0.969 |
股權 | 245.166 | 186.38 | 104.179 | 73.121 | 63.998 |
Preferred Stock - Non Redeemable, Net | 161.111 | ||||
普通股 | 0.003 | 0.003 | 0.002 | 0.002 | 0.001 |
額外實收資本 | 613.073 | 470.629 | 319.196 | 235.049 | 22.441 |
留存收益(累計赤字) | -367.884 | -284.046 | -214.842 | -161.95 | -118.953 |
其他權益,總計 | -0.026 | -0.206 | -0.177 | 0.02 | -0.602 |
總負債和股東權益 | 266.209 | 198.636 | 118.969 | 84.602 | 69.61 |
已發行普通股總數 | 34.2543 | 29.5551 | 24.7734 | 21.833 | 22.7504 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
短期投資 | 210.122 | 165.627 | 86.592 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 187.138 | 207.417 | 234.587 | 252.694 | 197.894 |
現金和短期投資 | 184.777 | 204.998 | 231.629 | 249.068 | 195.436 |
現金等價物 | 54.135 | 50.164 | 45.768 | 38.946 | 27.706 |
短期投資 | 130.642 | 154.834 | 185.861 | 210.122 | 167.73 |
預付的費用 | 2.361 | 2.419 | 2.958 | 3.626 | 2.458 |
總資産 | 199.721 | 220.756 | 248.326 | 266.209 | 209.489 |
物業/廠房/設備,總計 - 淨額 | 8.376 | 9.066 | 9.525 | 9.479 | 8.524 |
物業/廠房/設備,總計 - 總額 | 17.442 | 17.807 | 18.073 | 17.728 | 16.531 |
累計折舊,總計 | -9.066 | -8.741 | -8.548 | -8.249 | -8.007 |
其他長期資産,總計 | 4.207 | 4.273 | 4.214 | 4.036 | 3.071 |
流動負債總額 | 21.849 | 15.414 | 21.608 | 14.224 | 13.867 |
應付賬款 | 5.297 | 2.69 | 8.941 | 3.365 | 4.043 |
預提費用 | 16.499 | 12.628 | 12.626 | 10.827 | 9.791 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.053 | 0.096 | 0.041 | 0.032 | 0.033 |
負債總額 | 26.921 | 21.079 | 27.856 | 21.043 | 20.183 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 5.072 | 5.665 | 6.248 | 6.819 | 6.316 |
股權 | 172.8 | 199.677 | 220.47 | 245.166 | 189.306 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 |
額外實收資本 | 626.724 | 622.289 | 617.283 | 613.073 | 534.689 |
留存收益(累計赤字) | -453.806 | -422.435 | -397.155 | -367.884 | -344.933 |
其他權益,總計 | -0.121 | -0.18 | 0.339 | -0.026 | -0.453 |
總負債和股東權益 | 199.721 | 220.756 | 248.326 | 266.209 | 209.489 |
已發行普通股總數 | 34.3604 | 34.3521 | 34.2897 | 34.2543 | 29.8862 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -83.838 | -69.204 | -52.892 | -42.997 | -36.147 |
經營活動産生的現金 | -70.771 | -61.026 | -40.491 | -35.474 | -32.953 |
經營活動産生的現金 | 1.047 | 0.996 | 1.123 | 1.33 | 1.237 |
非現金物品 | 13.355 | 11.48 | 8.934 | 2.06 | 1.173 |
營運資金的變化 | -1.335 | -4.298 | 2.344 | 4.133 | 0.784 |
投資活動産生的現金 | -45.49 | -81.347 | -87.435 | -0.843 | -3.5 |
資本支出 | -0.845 | -0.755 | -0.398 | -0.888 | -3.5 |
融資活動産生的現金 | 131.18 | 141.482 | 75.461 | 49.902 | 52.734 |
股票的發行(報廢),淨額 | 131.18 | 141.482 | 75.461 | 49.902 | 52.734 |
現金淨變化 | 14.919 | -0.891 | -52.465 | 13.585 | 16.281 |
Cash Taxes Paid | 0 | 0.99 | 0.66 | ||
其他投資現金流量項目,總計 | -44.645 | -80.592 | -87.037 | 0.045 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -29.271 | -83.838 | -60.887 | -39.652 | -20.468 |
Cash From Operating Activities | -18.602 | -70.771 | -47.922 | -30.773 | -15.578 |
Cash From Operating Activities | 0.299 | 1.047 | 0.795 | 0.535 | 0.261 |
Non-Cash Items | 3.237 | 13.355 | 10.595 | 7.084 | 3.27 |
Changes in Working Capital | 7.133 | -1.335 | 1.575 | 1.26 | 1.359 |
Cash From Investing Activities | 25.308 | -45.49 | -4.22 | 13.379 | 23.837 |
Capital Expenditures | -0.759 | -0.845 | -0.796 | -0.715 | -0.149 |
Other Investing Cash Flow Items, Total | 26.067 | -44.645 | -3.424 | 14.094 | 23.986 |
Cash From Financing Activities | 0.116 | 131.18 | 55.821 | 50.57 | 0.132 |
Issuance (Retirement) of Stock, Net | 0.116 | 131.18 | 55.821 | 50.57 | 0.132 |
Net Change in Cash | 6.822 | 14.919 | 3.679 | 33.176 | 8.391 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
561 Eccles Ave
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易